1[1]Nestico PF, Morganroth J. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment. Cardiol Clin 1986, 4 (2): 285～ 303.
2[2]Hinkle LE, Carrer ST, Argyros DC. The prognostic significance of ventricular premature contractions in healthy people and people with cororary heart disease. Acta Cardiol (supple)1974, 18:5.
3[3]Fleg .JL, Kennedy HL. Cardiac arrhythmias in ahealthy elderly population:detection by 24 - hour ambulatory electrocardiography.Chest 1982, 81(3) :302～307.
4[4]Dhala A, Sra J, Blanck Z, et al. Ventricular arrhythmias, electrophysiologic studies, and devices. Cardiol Clin 1999, 17 (1): 189 ～195.
5[5]Bigger JT. Definition of benign versus malignant ventricular arrhythmias: targets for treatment. Am J Cardiol 1983, 52 (6): 47 ～54c.
6[6]Tresch DD, Platia EV, Reid PR, et al. Refractory symptomatic ventricular tachycardia and ventricular fibrillation in elderly patients.Am J Med 1987, 83.:399～404.
7[7]Van Gelder IC Brügemann J, Criius HJ. G. M. Pharmacological manbagement of arrhythmias in the elderly Drugs & Aging 1997,11(2) :96～ 110.
8[8]Cardiac Arrhythmia Suppression Trial(CAST) Investigators: Preliminary report:effect of encaihide and flecainide on mortaility in a randomize trial of arrhythmia suppression after myocardial infarction. N Engl.J Med 1989, 321:406～412.
9[9]Schaeffer WA, Cobb LA. Recurrent ventricular fibrillation and modes of death in surviors of out- of - hospital ventricular fibrilla-tion. N Eng J Med 1975, 293(6) :259～262.
